د. علي بن حمد الشهري                  
Dr. ALI H. D. ALSHEHRI

                                                                                                                 
                                                                                                                  
رئيس قسم العلوم الإشعاعية                                                                  
Chairman of Radiological Sciences Department


أستاذ مساعد  |  استشاري طب نووي 
متخصص ومهتم بأبحاث الطب النووي / التصوير- التشخيص- العلاج
قسم العلوم الإشعاعية
كلية العلوم الطبية التطبيقية

 

 Assistant professor | Nuclear Medicine Consultant 
PhD  | MSc in Nuclear Medicine |  BHSc Radiological Science 
Radiological Science Department
Applied Medical Sciences College

 



 


المؤهلات العلمية



 

الخبرات

التخصصات والمهارات

الدورات التدربية



 

 


 
 
  Advancing Internal Dosimetry in Personalized Nuclear Medicine: Toward Optimized Radiopharmaceutical Use in Clinical Practice
AHD Alshehri
Pharmaceuticals 18 (11), 1741
  2025
  Optimising Multimodal Image Registration Techniques: A Comprehensive Study of Non-Rigid and Affine Methods for PET/CT Integration
B Ali, MM Alqahtani, EM Alkhybari, AHD Alshehri, M Sayed, T Ali
Diagnostics 15 (19), 2484
  2025
  Enhancing dosimetric precision in the treatment of cancerous tumors: Gamma Index validation and Monte Carlo simulations of 6 and 12 megavoltage photon beams from Varian Medical …
AHD Alshehri
Frontiers in Oncology 15, 1573166
  2025
  Evaluating the Predictive Capability of Radiomics Features of Perirenal Fat in Enhanced CT Images for Staging and Grading of UTUC Tumours Using Machine Learning
A Al Mopti, A Alqahtani, AHD Alshehri, C Li, G Nabi
Cancers 17 (7), 1220
4 2025
  Perirenal fat CT radiomics-based survival model for upper tract urothelial carcinoma: integrating texture features with clinical predictors
A Al Mopti, A Alqahtani, AHD Alshehri, C Li, G Nabi
Cancers 16 (22), 3772
4 2024
  Bone-Targeting Radionuclides in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review on Radium-223 Chloride (Alpharadin) in Combination with Other Therapies
AHD Alshehri
Diagnostics 14 (21), 2407
3 2024
  Nuclear Medicine
A Alshehri, T Wright, KM Prise, A Cole
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 50 (SUPPL 1 …
  2023
  Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe
FDCG Liberal, H Moreira, KM Redmond, JM O’Sullivan, AHD Alshehri, ...
Frontiers in oncology 12, 877302
16 2022
  Abiraterone In Vitro Is Superior to Enzalutamide in Response to Ionizing Radiation
TC Wright, VL Dunne, AHD Alshehri, KM Redmond, AJ Cole, KM Prise
Frontiers in oncology 11, 700543
11 2021
  Radiobiological mechanisms and novel imaging biomarkers in metastatic prostate cancer treated with radium-223
AHD Alshehri
Queen's University Belfast
  2021
  A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer
AHD Alshehri, SOS Osman, KM Prise, C Campfield, PG Turner, ...
The British Journal of Radiology 93 (1115), 20200775
6 2020
  EP-2032 Automated Bone Scan Index (aBSI) as an Imaging Biomarker in Castration Sensitive Prostate Cancer
A Alshehri, J O'Sullivan, K Prise, S Jain, P Turner, C Campfield, S Biggart, ...
Radiotherapy and Oncology 133, S1115-S1116
  2019

 Nuclear Medicine Physics

 Nuclear Medicine Technology
Practical Training
 

الساعات المكتبية

الوصف

  8 - 9 9 - 10 10 - 11 11 - 12 12 - 1 1 - 2
الأحد
Sunday
           
الاثنين
Monday
 
ساعات مكتبية   
       
الثلاثاء
Tuesday
           
الأربعاء
Wednesday
           
الخميس
Thursday
 
ساعات مكتبية